Highlights
Trichomonas vaginalis causes the most common non-viral sexual transmitted infection (STI)
with annually 248 million new cases worldwide (1) . T. vaginalis occurs often as an asymptomatic infection and is in most cases untreated. When symptomatic, women may experience itch, changes in vaginal discharge, lower and upper reproductive tract disease syndromes, including vaginitis, cervicitis, increased risk for tubal pathology, and pelvic inflammatory disease (PID) (2, 3) . Untreated T. vaginalis infection affects sexual, reproductive and obstetric health and may facilitate transmission of other STIs, including an HIV infection.
T. vaginalis infections are more likely for HIV acquisition, an increased risk of preterm labor, an increased risk of PID, and an association is found between a T. vaginalis infection with a concurrent Chlamydia infection (4, 5) . A T. vaginalis infection is a curable STI, which is why diagnostic testing remains important to prevent complications.
Microscopic examination of wet mount smear and/or culture are the methods for detection of T. vaginalis and are currently most commonly used. However, wet mount is described to be insensitive compared to culture (53%) (6) . Another disadvantage of wet mount microscopy is that should be read within ten minutes of collection (6) . A disadvantage of culture is that T. vaginalis is undetectable for months after treatment with metronidazole in HIV positive women (7, 8) .
More sensitive techniques are DNA or RNA amplification tests to detect T. vaginalis: PCRbased methods report 40% more positive samples than culture (9 An often used method for detecting a T. vaginalis infection in women is culture of vaginal specimens. Culture, however, has a low sensitivity compared to the most currently introduced PCR methods and requires microscopic evaluation which is very time consuming and standardization of the interpretation of positivity is ambiguous (13) . In the last decade, several PCR tests have been developed and demonstrated to have a higher sensitivity and specificity than culture. Limited studies have been performed comparing culture and PCR for the detection of T. vaginalis. PCR has been compared to culture and sensitivity of 84% and 78% were obtained, respectively (14) . For that study, the Papanicolaou smear was used as the golden standard, which may lower the sensitivity.
Several studies compared PCR assays for the detection of T. vaginalis. For instance, the performance of Gen-Probe's transcription-mediated amplification (TMA) assay for T.
vaginalis has been compared to the BTUB FRET PCR and showed comparable results: TMA showed sensitivity and specificity of 98.6% and 99.1% (15) . One other study investigated the usefulness of several multiplex PCR assays for the detection of T. vaginalis. This study included the following tests: Anyplex™ II, Seeplex®, and AmpliSens®. The sensitivity for all three assays was 100.0%. The specificity was 99.9%, 100%, 99.4%, respectively. The PPV was evidently lower for two of their three assays than in our current study, which may be due to the low number of positive samples (n=8). The samples that were used in those studies included female swabs, female urine, and male urine (16) . Detection of T. vaginalis by PCR in urine specimens is described to be not appropriate in women, whereas detection by PCR in vaginal swabs is a more sensitive method (17) .
This is the first comparison study for detection of T. vaginalis with a high number of true positive samples (n=103) after calculation against the alloyed standard. In the current study we observed 17% positive samples, after discordancy analysis.
Although this is the largest comparison study for detection of T. vaginalis to date, our number of samples could have been higher, but that has been balanced by the high amount of positive samples found. This makes both tests suitable for detecting a T. vaginalis infection at one infection site. Both assays performed comparably on this study population with a high amount of positive samples and are therefore suitable for detection of T.
vaginalis.
The evaluation of dry and wet swabs has been described in detection of C. trachomatis and N. gonnorrhoeae. That study concludes that the dry swab was as accurate as the wet swab (18) . A study by Eperon et al. concluded that swabs can be successfully transported in a dry state at ambient temperature without greatly altering specimen integrity (19) . The performances of dry swabs was previously been studied in comparison with wet swabs. Dry swabs performed as accurately as wet swabs for trichomonas at low, moderate, and high concentrations (20) . Due to the performance of the dry swabs in several other studies, we chose to use dry swabs.
We previously compared the dual detecting Presto assay with the currently widely used cobas® 4800 CT/NG test for the detection of C. trachomatis and N. gonorrhoeae using dry collected vaginal and rectal swabs with the same study population (10) . For C. trachomatis we detected 13% positive vaginal samples and 6.7% positive rectal samples. In the current study, we did not include rectal samples, due to only one positive T. vaginalis sample. The C. trachomatis and N. gonorrhoeae results from the triple detecting Presto plus assay were comparable with the results from the Presto assay (data not shown), so dry swabs appear to perform well and are useful for C. trachomatis and N. gonorrhoeae.
In conclusion, good diagnostics are essential for prevention of further spreading of STI in the healthy population. Therefore diagnostic tests should display high sensitivity whereas falsepositives have to be excluded at any time. The Presto plus assay combines multiple pathogens in a single assay, which provides new diagnostic insights and cost effectiveness.
